ANPC - AnPac Bio-Medical Science GAAP EPS of -$0.39 revenue of $1.75M May, 16 2023 04:49 PM AnPac Bio-Medical Science Co. Ltd. 2023-05-16 16:49:11 ET AnPac Bio-Medical Science press release ( NASDAQ: ANPC ): Q1 GAAP EPS of -$0.39. Revenue of $1.75M (+464.5% Y/Y). Non-GAAP net loss was ~$12.9M. For further details see: AnPac Bio-Medical Science GAAP EPS of -$0.39, revenue of $1.75M